DETAILED NOTES ON HIV TREATMENT

Just one place mutation, V6A, introduced to the molecule significantly improved the toxicity profile and reduced VLS as compared to the WT molecule [76]. Additional studies and clinical trials are going to be vital to determine if this modified construct has improved basic safety and efficacy in individuals.A variety of dosages of IL-two throughout